Medication info

Ranitidine 150 mg (Ranitidine Hydrochloride)

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›168mg / 1 tablet
Manufacturer / importer
(Yoo) Hanpoong Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
100 tablets/PTP[(10 tablets/PTP*10)], 300 tablets/bottle
Approval status
Expired

MFDS item code 201905480 · Approved 2019.08.01

This product's status changed to Expired on 2024.08.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related diseases (including ulcers and esophagitis); improvement of gastric mucosal lesions; prevention of Mendelson syndrome
Who takes it
Adults · Children
Adult dose
Adults Administer ranitidine 150 mg per dose orally twice daily, in the morning and at bedtime. Gastric and duodenal ulcers Administer 150 mg per dose twice daily or 300 mg once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 300 mg per dose twice daily, in the morning and at bedtime. The dosage and administration are the same for concomitant therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. These conditions usually heal within 4 weeks, and conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. Gastroesophageal reflux disease Administer 150 mg per dose twice daily for 8 weeks or 300 mg once daily at bedtime. The dose may be increased to 150 mg per dose 4 times daily in patients with severe gastroesophageal reflux disease. Zollinger-Ellison syndrome Initiate treatment with an initial dose of 150 mg per dose 3 times daily; the dose may be increased as needed. In severe cases, up to 6 g daily may be administered as directed by a physician. For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is usually initiated with an injection. Once oral administration becomes possible, switch to oral administration of 150 mg per dose twice daily. Preanesthetic medication (prevention of Mendelson's syndrome) Administer 150 mg 2 hours before induction of anesthesia. In this case, it is preferable to also administer 150 mg on the night before surgery. Improvement of gastric mucosal lesions (erosions, bleeding, erythema, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer 150 mg per dose once daily at bedtime. Patients with renal impairment For patients with severe renal impairment with creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the drug; therefore, readjust the dosing schedule immediately after hemodialysis. The dose may be adjusted according to age and symptoms.
Child dose
For ages 8 〜 18 years, 150 mg per dose (2 mg per kg of body weight) may be administered up to twice daily.

Ingredients

Manufacturer
(Yoo) Hanpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related diseases (including ulcers and esophagitis); improvement of gastric mucosal lesions; prevention of Mendelson syndrome

  • Gastric ulcer
  • duodenal ulcer
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcer
  • gastric ulcer due to NSAID administration
  • duodenal ulcer due to NSAID administration
  • gastric mucosal erosion
  • gastric mucosal bleeding
  • gastric mucosal erythema
  • gastric mucosal edema
View approved original text

This medication is used for the treatment of gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also effective for the prevention of Mendelson's syndrome before anesthesia and for the treatment of postoperative ulcers, as well as ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs). Additionally, it is used for the acute exacerbation of acute and chronic gastritis and for the improvement of gastric mucosal lesions (erosions, bleeding, erythema, edema). It is effective even when there is upper gastrointestinal bleeding. It is widely used for the treatment of gastrointestinal diseases by protecting the gastric mucosa and aiding in its recovery.

How to take

Adult dose

Adults Administer ranitidine 150 mg per dose orally twice daily, in the morning and at bedtime. Gastric and duodenal ulcers Administer 150 mg per dose twice daily or 300 mg once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 300 mg per dose twice daily, in the morning and at bedtime. The dosage and administration are the same for concomitant therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. These conditions usually heal within 4 weeks, and conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. Gastroesophageal reflux disease Administer 150 mg per dose twice daily for 8 weeks or 300 mg once daily at bedtime. The dose may be increased to 150 mg per dose 4 times daily in patients with severe gastroesophageal reflux disease. Zollinger-Ellison syndrome Initiate treatment with an initial dose of 150 mg per dose 3 times daily; the dose may be increased as needed. In severe cases, up to 6 g daily may be administered as directed by a physician. For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is usually initiated with an injection. Once oral administration becomes possible, switch to oral administration of 150 mg per dose twice daily. Preanesthetic medication (prevention of Mendelson's syndrome) Administer 150 mg 2 hours before induction of anesthesia. In this case, it is preferable to also administer 150 mg on the night before surgery. Improvement of gastric mucosal lesions (erosions, bleeding, erythema, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer 150 mg per dose once daily at bedtime. Patients with renal impairment For patients with severe renal impairment with creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the drug; therefore, readjust the dosing schedule immediately after hemodialysis. The dose may be adjusted according to age and symptoms.

Child dose

For ages 8 〜 18 years, 150 mg per dose (2 mg per kg of body weight) may be administered up to twice daily.

Precautions

This drug should not be used in patients with a history of hypersensitivity to its components or acute porphyria. In patients with impaired renal function, the blood concentration of this drug may increase, so it should be used with caution by reducing the dose or increasing the dosage interval. Caution is also needed in patients with impaired liver function. Patients with a history of hypersensitivity, elderly patients, and patients taking NSAIDs should have their condition monitored regularly while taking this medication. Since this drug may mask symptoms of gastric cancer, patients with gastric ulcers or middle-aged patients with newly occurring dyspepsia should only use it after confirming there is no malignancy. For patients with Helicobacter pylori-associated gastric and duodenal ulcers, it is recommended to also conduct eradication therapy. This drug can rarely cause serious allergic reactions, blood abnormalities, liver dysfunction, gastrointestinal symptoms, neurological abnormalities, skin rashes, and various side effects, so if unusual symptoms appear, the drug should be stopped immediately and a doctor consulted. It is important to regularly check for abnormalities through blood tests and liver-kidney function tests during treatment. Elderly patients, patients with chronic lung disease, diabetes, and those with weakened immune systems may have an increased risk of pneumonia when taking this medication. If dizziness or drowsiness occurs after taking this drug, it is safer to avoid driving or operating hazardous machinery. Furthermore, this drug can affect the absorption or metabolism of other medications, so if you are taking other drugs, you must consult a doctor or pharmacist. In pregnant or breastfeeding women, the effects of this drug on the fetus or baby are not fully known, so it should be used cautiously only when necessary. Safety for children has not been adequately established, thus special precautions are needed for pediatric patients. In case of overdose, measures such as vomiting or gastric lavage should be taken, and if necessary, hemodialysis can be performed to remove the drug, so inform medical staff immediately in emergencies. This drug should be stored out of reach of children, and it is advisable not to transfer it to other containers. Long-term use could affect the eyes, so regular ophthalmologic examinations are recommended.

Side effects

  • Anaphylactic shock
  • urticaria
  • angioedema
  • rash
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • elevated serum creatinine
Show 52 more
  • leukopenia
  • thrombocytopenia
  • myelosuppression
  • aplastic anemia
  • refractory anemia
  • agranulocytosis
  • pancytopenia
  • acquired immune hemolytic anemia
  • eosinophilia
  • liver dysfunction
  • jaundice
  • hepatitis
  • bradycardia
  • atrioventricular block
  • tachycardia
  • vasculitis
  • constipation
  • nausea
  • vomiting
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • diarrhea
  • acute pancreatitis
  • dizziness
  • drowsiness
  • seizures
  • headache
  • heaviness in the head
  • insomnia
  • agitation
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • altered consciousness
  • hepatic myoclonus
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • glossitis
  • pruritus
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a tightly sealed container to prevent air from entering, and it is best kept in a dry place at room temperature between 1°C and 30°C. By storing it this way, the effectiveness of the medication can be maintained for a long time.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

100 tablets/PTP[(10 tablets/PTP*10)], 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.